Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2021.46034
Abstract: The optimal international normalized ratio (INR) target for warfarin therapy has evolved through decades of use as additional information sheds light on the best balance between preventing pathologic thrombus formation while limiting bleeding complications. The… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0625
Abstract: Key Points Question Is the administration of tranexamic acid associated with mortality and thromboembolic events in patients with traumatic injury? Findings This systematic review and meta-analysis included 31 randomized clinical trials and observational studies with… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.1562
Abstract: The article by Citro et al.1 published in the European Journal of Heart Failure describes the outcome of Takotsubo syndrome (TTS) patients presenting with severely reduced left ventricular ejection fraction (LVEF≤ 35%) on admission. Recent… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12458
Abstract: There are limited data on the outcomes of adults with coronavirus disease 2019 (COVID‐19) and atrial fibrillation (AF). The objectives were to (i) examine associations between AF, 30‐day thromboembolic events and mortality in adults with… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12113
Abstract: Abstract Pulmonary thromboembolic events have been linked to coronavirus disease 2019 (COVID‐19), but their incidence and long‐term sequelae remain unclear. We performed a systematic literature review to investigate the incidence of pulmonary embolism (PE), microthrombi,… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Rheumatology"
DOI: 10.1007/s10067-022-06140-z
Abstract: To investigate the clinical characteristics and risk factors for thromboembolic events in patients with idiopathic inflammatory myopathy (IIM). We retrospectively analyzed 1144 consecutive patients with IIM for arterial and venous thromboses and compared them with… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02163-y
Abstract: The COVID-19 pandemic affects more than two million people to date with a high prevalence of thromboembolic events (TEE) and disseminated intravascular coagulation (DIC) [1, 2]. Tang et al. [3] recently reported that it would… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02319-w
Abstract: New oral anticoagulants (NOACs) is the preferred treatment in secondary prophylaxis of venous thromboembolic events (VTE). The aim of this study was to investigate possible risk factors associated with major bleeding in VTE-patients treated with… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "American journal of surgery"
DOI: 10.1016/j.amjsurg.2016.10.037
Abstract: BACKGROUND We evaluated postoperative venous thromboembolism (VTE) chemical prophylaxis adherence to assess the preventability of VTEs. METHODS A case-control study was performed using the 2011-2015 ACS-NSQIP single institution database. Cases were identified as patients who… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of Vascular Surgery"
DOI: 10.1016/j.avsg.2021.12.068
Abstract: INTRODUCTION/OBJECTIVES COVID-19 is associated with a prothrombotic state and elevated risk of thromboembolism. This study assesses the risk of thromboembolic events and their impact on hospitalization of COVID-19 inpatients. Image, table 1 Image, table 1… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Blood reviews"
DOI: 10.1016/j.blre.2017.10.002
Abstract: Venous thromboembolic events (VTE) are an underestimated health problem in patients with lymphoma. Many factors contribute to the pathogenesis of thromboembolism and the interplay between various mechanisms that provoke VTE is still poorly understood. The… read more here.